We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

89 hedge funds and large institutions have $773M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

149% more capital invested

Capital invested by funds: $310M → $773M (+$463M)

95% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 19

25% more funds holding

Funds holding: 71 → 89 (+18)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
89
Holders Change
+18
Holders Change %
+25.35%
% of All Funds
2.37%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
37
Increased
22
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.7M
2
DM
Deerfield Management
New York
+$12.8M
3
BFA
BlackRock Fund Advisors
California
+$10.6M
4
Jennison Associates
Jennison Associates
New York
+$8.97M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$8.64M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$7.57M
2
VAM
Visium Asset Management
New York
-$4.71M
3
Millennium Management
Millennium Management
New York
-$3.77M
4
EA
Emerald Advisers
Pennsylvania
-$2.8M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
51
Public Employees Retirement Association of Colorado
Colorado
$799K +$447K +15,232 New
Bank of America
52
Bank of America
North Carolina
$744K +$320K +10,889 +331%
TA
53
Teachers Advisors
New York
$659K +$90.8K +3,093 +33%
Swiss National Bank
54
Swiss National Bank
Switzerland
$609K +$38.2K +1,300 +13%
TAM
55
Tocqueville Asset Management
New York
$562K +$314K +10,700 New
Renaissance Technologies
56
Renaissance Technologies
New York
$535K +$300K +10,200 New
WMSA
57
Weiss Multi-Strategy Advisers
New York
$525K +$294K +10,000 New
TI
58
Trexquant Investment
Connecticut
$498K +$279K +9,495 New
Citigroup
59
Citigroup
New York
$476K +$204K +6,953 +329%
ARTA
60
A.R.T. Advisors
New York
$456K +$256K +8,702 New
NFA
61
Nationwide Fund Advisors
Ohio
$453K -$1.79K -61 -0.7%
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$441K +$247K +8,400 New
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$422K – – –
Two Sigma Investments
64
Two Sigma Investments
New York
$409K +$229K +7,800 New
Citadel Advisors
65
Citadel Advisors
Florida
$407K +$228K +7,752 New
Wellington Management Group
66
Wellington Management Group
Massachusetts
$359K +$201K +6,840 New
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$347K +$194K +6,605 New
NSEDCP
68
NJ State Employees Deferred Compensation Plan
New Jersey
$346K +$194K +6,600 New
HCM
69
Harvey Capital Management
Florida
$333K +$186K +6,350 New
AIG
70
American International Group
New York
$307K +$16.4K +559 +11%
BA
71
BlackRock Advisors
Delaware
$278K -$207K -7,054 -57%
RFS
72
Rockefeller Financial Services
New York
$247K +$138K +4,705 New
Goldman Sachs
73
Goldman Sachs
New York
$246K +$138K +4,693 New
EMG
74
Ellington Management Group
Connecticut
$226K +$126K +4,300 New
Two Sigma Advisers
75
Two Sigma Advisers
New York
$210K +$117K +4,000 New
1 2
3
4 5

ASPX Hedge Fund Activity: Q4 2014 in Review

89 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q4 2014, worth a combined $773M — up 149% from $310M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASPX positions and 19 closed out — a net gain of 18 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $42.7M. The largest seller was Ameriprise, cutting an estimated $7.57M.

  • 89 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q4 2014, up from 71 in Q3 2014.
  • Funds reported $773M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, up 149% quarter-over-quarter.
  • 37 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 19 closed out, a net change of +18 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Fidelity Investments, an estimated $42.7M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Ameriprise, an estimated $7.57M sold.

Based on aggregated 13F filings for Q4 2014.